Regeneron Pharmaceuticals shares owned by Davern Capital Partners
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Davern Capital Partners
from 13F filings
Historical chart of Davern Capital Partners investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Davern Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Davern Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $41M | 52k | 771.87 |